Results 251 to 260 of about 29,796 (299)

SFX-01 is therapeutic against myeloproliferative disorders caused by activating mutations in Shp2. [PDF]

open access: yesEMBO Mol Med
Cho HJ   +19 more
europepmc   +1 more source

Harnessing GSK-3β inhibition for lung cancer therapy: emerging opportunities and challenges. [PDF]

open access: yesMed Oncol
Hassanein EHM   +4 more
europepmc   +1 more source

Antirheumatic effect of Sulforaphan

open access: yes, 2008
Wruck, C   +5 more
openaire   +1 more source

Home - About - Disclaimer - Privacy